Kokici J, Preechanukul A, Arellano-Ballestero H, Gorou F, Peppa D
Viruses. 2024; 16(11).
PMID: 39599860
PMC: 11599065.
DOI: 10.3390/v16111746.
Sokolov D, Gorshkova A, Tyshchuk E, Grebenkina P, Zementova M, Kogan I
Int J Mol Sci. 2024; 25(17).
PMID: 39273424
PMC: 11395174.
DOI: 10.3390/ijms25179478.
Gunasena M, Alles M, Wijewantha Y, Mulhern W, Bowman E, Gabriel J
Arterioscler Thromb Vasc Biol. 2024; 44(10):e243-e261.
PMID: 38989579
PMC: 11448863.
DOI: 10.1161/ATVBAHA.124.321085.
Mugo R, Oser L, Midha A, Adjah J, Kundik A, Laubschat A
Sci Rep. 2024; 14(1):14586.
PMID: 38918457
PMC: 11199589.
DOI: 10.1038/s41598-024-64497-4.
Kupke P, Brucker J, Wettengel J, Protzer U, Wenzel J, Schlitt H
Viruses. 2024; 16(5).
PMID: 38793623
PMC: 11125674.
DOI: 10.3390/v16050741.
In Vivo Zymosan Treatment Induces IL15-Secreting Macrophages and KLRG1-Expressing NK Cells in Mice.
Park H, Lee S, Park Y, Kim T, Lee S, Lee S
Molecules. 2023; 28(15).
PMID: 37570749
PMC: 10421142.
DOI: 10.3390/molecules28155779.
Defining the role of natural killer cells in COVID-19.
Lee M, Blish C
Nat Immunol. 2023; 24(10):1628-1638.
PMID: 37460639
PMC: 10538371.
DOI: 10.1038/s41590-023-01560-8.
Natural killer cells in the lung: potential role in asthma and virus-induced exacerbation?.
Lepretre F, Gras D, Chanez P, Duez C
Eur Respir Rev. 2023; 32(169).
PMID: 37437915
PMC: 10336552.
DOI: 10.1183/16000617.0036-2023.
Transcriptional and chromatin profiling of human blood innate lymphoid cell subsets sheds light on HIV-1 pathogenesis.
Wang Y, Lifshitz L, Silverstein N, Mintzer E, Luk K, StLouis P
EMBO J. 2023; 42(16):e114153.
PMID: 37382276
PMC: 10425848.
DOI: 10.15252/embj.2023114153.
Leishmaniasis: Immune Cells Crosstalk in Macrophage Polarization.
Almeida F, Vanderley S, Comberlang F, de Andrade A, Cavalcante-Silva L, Silva E
Trop Med Infect Dis. 2023; 8(5).
PMID: 37235324
PMC: 10222886.
DOI: 10.3390/tropicalmed8050276.
Modulation of NK cell activation by exogenous calcium from alginate dressings .
Adib Y, Boy M, Serror K, Dulphy N, Courtils C, Duciel L
Front Immunol. 2023; 14:1141047.
PMID: 37090742
PMC: 10117844.
DOI: 10.3389/fimmu.2023.1141047.
Monocyte and Macrophage in Neuroblastoma: Blocking Their Pro-Tumoral Functions and Strengthening Their Crosstalk with Natural Killer Cells.
Vitale C, Bottino C, Castriconi R
Cells. 2023; 12(6).
PMID: 36980226
PMC: 10047506.
DOI: 10.3390/cells12060885.
The role of macrophages-mediated communications among cell compositions of tumor microenvironment in cancer progression.
Li M, Jiang P, Wei S, Wang J, Li C
Front Immunol. 2023; 14:1113312.
PMID: 36845095
PMC: 9947507.
DOI: 10.3389/fimmu.2023.1113312.
Interaction of tumor‑associated macrophages with stromal and immune components in solid tumors: Research progress (Review).
Kazakova A, Sudarskikh T, Kovalev O, Kzhyshkowska J, Larionova I
Int J Oncol. 2023; 62(2).
PMID: 36660926
PMC: 9851132.
DOI: 10.3892/ijo.2023.5480.
Hepatic damage caused by long-term high cholesterol intake induces a dysfunctional restorative macrophage population in experimental NASH.
Maretti-Mira A, Salomon M, Hsu A, Kanel G, Golden-Mason L
Front Immunol. 2022; 13:968366.
PMID: 36159810
PMC: 9495937.
DOI: 10.3389/fimmu.2022.968366.
Progressive Host-Directed Strategies to Potentiate BCG Vaccination Against Tuberculosis.
Negi K, Bhaskar A, Dwivedi V
Front Immunol. 2022; 13:944183.
PMID: 35967410
PMC: 9365942.
DOI: 10.3389/fimmu.2022.944183.
Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications.
Di Vito C, Calcaterra F, Coianiz N, Terzoli S, Voza A, Mikulak J
Front Immunol. 2022; 13:888248.
PMID: 35844604
PMC: 9279859.
DOI: 10.3389/fimmu.2022.888248.
NK Cells, Monocytes and Macrophages in HIV-1 Control: Impact of Innate Immune Responses.
Mensching L, Hoelzemer A
Front Immunol. 2022; 13:883728.
PMID: 35711433
PMC: 9197227.
DOI: 10.3389/fimmu.2022.883728.
Adaptive MHC-E restricted tissue-resident NK cells are associated with persistent low antigen load in alveolar macrophages after SARS-CoV-2 infection.
Huot N, Planchais C, Contreras V, Jacquelin B, Petitdemange C, Lazzerini M
Res Sq. 2022; .
PMID: 35547853
PMC: 9094104.
DOI: 10.21203/rs.3.rs-1561222/v1.
CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk.
Baer C, Kimura S, Rana M, Kleist A, Flerlage T, Feith D
Nat Genet. 2022; 54(5):637-648.
PMID: 35513723
PMC: 9117519.
DOI: 10.1038/s41588-022-01059-2.